Standard Neoadjuvant Chemotherapy Versus Genomic Driven Chemotherapy in Patients With Breast Cancer

NCT01180335 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

303

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Chemotherapy
DRUG: Genomic driven chemotherapy

Sponsor

Gustave Roussy, Cancer Campus, Grand Paris

Collaborators

[object Object]